Review of boceprevir and telaprevir for the treatment of chronic hepatitis C
Canadian Journal of Gastroenterology,  Clinical Article

Wilby KJ et al. – Boceprevir and telaprevir will revolutionize the management of hepatitis C genotype 1 patients and will most likely decrease the burden of end–stage disease worldwide. However, current clinical limitations include establishing appropriate and cost–effective treatment durations, and use in special populations such as transplant patients and patients coinfected with HIV. Future research will need to clarify these clinical obstacles to clearly define the role of these agents in hepatitis C management.

Methods
  • A standardized search strategy was performed using the MEDLINE, EMBASE, Google Scholar and International Pharmaceuticals Abstracts databases using the search terms "boceprevir", "telaprevir", "boceprevir and hepatitis C" and "telaprevir and hepatitis C".
  • A manual search of references was performed to identify articles missed by the electronic search.
  • Studies were included in the review if they assessed either boceprevir or telaprevir in comparison with standard of care in chronic hepatitis C patients.

Results
  • The studies identified assessed boceprevir and telaprevir in genotype-1 hepatitis C patients.
  • In both treatment-naive and treatment-experienced patients, sustained virological response rates were achieved more often with boceprevir or telaprevir in combination with pegylated interferon and ribavirin compared with pegylated interferon and ribavirin alone.
  • Both medications were well tolerated, with anemia presenting as the most treatment-limiting adverse effect.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Infectious Disease

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Infectious Disease Articles

1 Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: A meta-analysis International Journal of Antimicrobial Agents, April 25, 2014    Review Article

2 Xpert MTB/RIF assay shortens airborne isolation for hospitalized patients with presumptive tuberculosis in the United States Clinical Infectious Diseases, July 2, 2014    Clinical Article

3 HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial The Journal of Infectious Diseases, July 8, 2014    Clinical Article

4 Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America Clinical Infectious Diseases, June 20, 2014    Clinical Article

5 Vertical transmission of hepatitis C virus: Systematic review and meta-analysis Clinical Infectious Diseases, July 24, 2014    Evidence Based Medicine    Review Article

6 Infectious causes of stroke The Lancet Infectious Diseases, May 30, 2014    Clinical Article

7 Safety of vaccines used for routine immunization of US children: A systematic review Pediatrics, July 11, 2014    Clinical Article

8 High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: A comparative study Diagnostic Microbiology and Infectious Disease, June 9, 2014    Clinical Article

9 The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral aetiology: A systematic review and exploratory meta-analysis The Journal of Infectious Diseases, July 23, 2014    Clinical Article

10 Statins use and risk of mortality in patient with Clostridium difficile infection Clinical Microbiology and Infection, May 12, 2014    Clinical Article

11 Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: A phase I/II, randomized trial AIDS, July 14, 2014    Clinical Article

12 Breastfeeding and HIV-infected women in the United States: Harm reduction counseling strategies Clinical Infectious Diseases, July 1, 2014    Review Article

13 Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infection Journal of Viral Hepatitis, July 14, 2014    Clinical Article

14 The return of the big three killers Clinical Microbiology and Infection, July 30, 2013    Clinical Article

15 Ethanol versus heparin locks for the prevention of central venous catheter-associated bloodstream infections: A randomized trial in adult haematology patients with Hickman devices Journal of Hospital Infection, July 10, 2014    Clinical Article

16 The efficacy of daptomycin versus vancomycin for methicillin-resistant staphylococcus aureus bloodstream infection in patients with impaired renal function Clinical Infectious Diseases, April 21, 2014    Clinical Article

17 Sofosbuvir and ribavirin for hepatitis c in patients with hiv coinfection JAMA, July 30, 2014    Evidence Based Medicine    Clinical Article

18 Cancer treatment disparities in HIV-infected individuals in the United States Journal of Clinical Oncology, July 22, 2014    Clinical Article

19 Prevalence and risk factors for asymptomatic clostridium difficile carriage Clinical Infectious Diseases, July 2, 2014    Clinical Article

20 Association between chronic hepatitis C virus infection and low muscle mass in US adults Journal of Viral Hepatitis, July 3, 2014    Clinical Article

Indexed Journals in Infectious Disease: Journal of Infection, AIDS, American Journal of Infection Controlmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close